about
Diagnosis and Treatment of Multiple Primary Lung CancerA multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer.A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea: a population-based investigation.Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practiceTopotecan: An evolving option in the treatment of relapsed small cell lung cancer.Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer.EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.Prophylactic cranial irradiation for small-cell lung cancer: how, when and for whom?Lung cancer in octogenarians: factors affecting long-term survival following resection.Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer.Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer.Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer.Safety and efficacy of paclitaxel liposome for elderly patients with advanced non-small cell lung cancer: A multi-center prospective study.Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.
P2860
Q28067958-33EB2497-1DDD-47AE-858F-9A342AA755AEQ33409548-CB5D5108-0D48-4E64-A923-DD053AABEA18Q33655643-3A89CB91-B27D-496D-99B0-F030D613B329Q33908633-BF02FF0F-E892-4FDD-8FDD-44309691B435Q36663697-1E3128AE-A170-4D9D-A71E-C1F53565A8A8Q37389608-31F71C70-3839-42B2-A719-010F786DCB14Q37589341-461B1BAD-E5BD-43EB-9968-77EC62884EC9Q38002472-92DA04FE-A0AD-4168-ACBC-12526B6EB653Q43453076-C3FC98DE-F052-4E36-8C93-57622129ECF0Q47429827-B24AEBBF-7C4F-4B2F-B6A0-A7C687AA8D12Q48353696-ED43ECD6-8E24-406A-BB3D-367A1F50F79DQ49369007-C16B4A5F-62A7-4994-8F3B-4D309265408CQ50050078-D07F9A68-E526-4683-AF26-05276E450D95Q53323484-F7F1EEEB-FAEA-4975-8C57-C7327381B721
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Management of lung cancer in older adults.
@ast
Management of lung cancer in older adults.
@en
type
label
Management of lung cancer in older adults.
@ast
Management of lung cancer in older adults.
@en
prefLabel
Management of lung cancer in older adults.
@ast
Management of lung cancer in older adults.
@en
P1433
P1476
Management of lung cancer in older adults.
@en
P2093
Arti Hurria
Mark G Kris
P304
P356
10.3322/CANJCLIN.53.6.325
P407
P577
2003-11-01T00:00:00Z